Homocysteine (Hcy) is a sulfur-containing non-proteinogenic amino acid formed during the
metabolism of the essential amino acid methionine. Hcy is considered a risk factor for …

High level of homocysteine (hyperhomocysteinemia, HHcy) is associated with increased risk
for vascular disease. Evidence for this emerges from epidemiological studies which show …

Homocysteine (Hcy) is a non-protein forming amino acid which is the direct metabolic
precursor of methionine. Increased concentration of serum Hcy is considered a risk factor for …

Homocysteine is a sulphur‐containing non‐proteinogenic amino acid.
Hyperhomocysteinaemia (HHcy), the pathogenic elevation of plasma homocysteine as a …

Homocysteine (Hcy) is an intermediate amino acid formed during the conversion from
methionine to cysteine. When the fasting plasma Hcy level is higher than 15 μmol/L, it is …

Homocysteine, a sulphur-containing amino acid derived from methionine, has been
presented as an independent risk factor for cardiovascular disorders, including …

Homocysteine, a non-protein amino acid, is an important risk factor for ischemic heart
disease and stroke in humans. This review provides an overview of homocysteine influence …

While the role of hyperhomocysteinemia in cardiovascular pathogenesis continuously draws
attention, deficiency of hydrogen sulfide (H2S) has been growingly implicated in …

Elevated plasma levels of homocysteine are a metabolic risk factor for atherosclerotic
vascular disease, as shown in numerous clinical studies that linked elevated homocysteine …

Hyperhomocysteinemia is an independent risk factor for the development of atherosclerosis.
An increasing body of evidence has implicated oxidative stress as being contributory to …